Business Wire

SEMPERIS

Share
Semperis Brings Award-Winning Hybrid Identity Protection Conference to Europe, Keynotes Announced

Semperis , the pioneer in identity-driven cyber resilience for enterprises, today announced that it will host the inaugural Hybrid Identity Protection (HIP) Europe Virtual Conference 2021 , taking place virtually on 30 June and 1 July 2021. The first European edition of the award-winning global Hybrid Identity Protection conference series, HIP Europe will bring together leading experts working at the intersection between identity and security to provide a deep dive into the latest trends and challenges in managing hybrid and multi-cloud environments.

Keynote speakers will include Microsoft MVP Tony Redmond , aka the Exchange Godfather and author of numerous books and blogs on Microsoft Exchange and Office 365, and Microsoft Directory Services MVP and identity guru John Craddock , who has played a key role architecting identity and security solutions for industry leaders including Microsoft, the UK Government and multi-national businesses.

Organisations globally are struggling to keep up with the skyrocketing proliferation of cyberattacks — including the infamous SolarWinds supply-chain attack and the Hafnium attack on Microsoft Exchange — that target identity systems, especially Active Directory. HIP Europe will connect technology gurus and practitioners in an environment where they can exchange information, share war stories, and ultimately make their networks and applications more secure.

The HIP conference has earned its place as the premier educational forum for identity-centric cybersecurity leaders tasked with defending hybrid environments. First established in the US and now coming to Europe, the conference series is designed to advance the skills of IT and cybersecurity professionals through highly technical demonstrations, expert roundtables, and networking sessions. Attendees will learn best practices from local identity and access management (IAM) experts and Microsoft Most Valuable Professionals (MVPs), and connect with peers facing similar infrastructure and security challenges.

Agenda highlights

The two-day conference programme is packed with actionable insights for practitioners, from discussing the future of cloud security to identifying and recovering from directory breaches and cyber disasters. Highlights include:

  • The Future of Microsoft Cloud Services . In this keynote session, Tony Redmond will look at the economics, software engineering, ecosystem and landscape of Microsoft 365 and discuss the reliability and security of Office 365.
  • The Future of Identity: DIDs and VCs . This keynote by John Craddock will be an introduction to the future of identity with Decentralised Identifiers (DIDs) and Verifiable Credentials (VCs). What if users owned their identity without dependence on identity providers and only needed to prove who they are once, using that proof as often as necessary?
  • Cloud Security: What’s Next? Providing a simple and unified hybrid security management engine that spans the heterogeneous space of on-premises, shared data centre and cloud is a key challenge. This session will sketch the current cloud security landscape and what challenges lie ahead for hybrid organisations.
  • Deploying a Zero Trust Infrastructure . This session will demonstrate how to implement the principles of Zero Trust within a Microsoft hybrid cloud infrastructure, building on the Microsoft security stack with Azure AD, Control and Conditional Access Management features and Microsoft 365 Defender suite.

Keynote speaker and identity guru John Craddock comments: “Almost all organisations consume services from the cloud and are possibly shifting their own services to the cloud, building valuable collaborative environments providing access for their users, partners and consumers. The security boundary stretches and morphs as we create these new hybrid systems. With these elastic boundaries, identity becomes the critical component in securing our assets and managing access control. At the Hybrid Identity Protection conference, attendees can learn from industry leaders how to identify potential vulnerabilities and protect their systems for the future. A paradigm shift is around the corner with Decentralised Identity and Verifiable Credentials. My keynote will explain the benefits of this exciting new technology.”

Guido Grillenmeier, Chief Technologist at Semperis and Microsoft MVP alumnus for Directory Services, adds: “We’re excited to bring the HIP conference to Europe for the first time. It promises an amazing line-up of the world’s foremost hybrid identity experts covering today’s hottest identity security topics: the future of cloud services, cloud security and identity itself. Zero Trust is the name of the game when it comes to preventing malicious actors from stealing the keys to your kingdom – your most privileged accounts – be it on-premises or in the cloud. HIP Europe will give solid insights into how it is done right. Due to the pandemic, this will be a fully virtual experience, and it is free to attend. Security professionals can expect to discuss learnings from recent cyber incidents, experiences in recovering from attacks and how to defend modern environments against emerging threats.”

The global HIP event was established by Semperis in 2016 and has won several awards, including the 2021 Globee Business Awards – Gold Winner, Achievement of the Year in Live Events, the 2020 Cybersecurity Excellence Awards – Best Cybersecurity Conference, the Golden Bridge Business and Innovation Awards – Gold Winner, Live Event of the Year, and the 2020 IT World Awards – Bronze Winner, Security Awareness Computer-Based Training.

HIP Europe attendees can qualify for up to 12 continuing professional education (CPE) credits.

The full conference agenda is available: https://www.accelevents.com/e/HIPEurope#agenda

Registration is free: https://www.accelevents.com/e/u/checkout/HIPEurope/tickets/order

About Hybrid Identity Protection

Mobile workforces, cloud applications and digitalisation are changing every aspect of the modern enterprise. And with radical transformation come new business risks. Hybrid Identity Protection (HIP) is the premier educational forum for identity-centric practitioners. Whatever industry sector or job function, HIP strives to provide its community the insights and relationships needed to enable and protect today’s digitally driven organisations.

Twitter https://twitter.com/HIPConf
LinkedIn https://www.linkedin.com/company/hybrid-identity-protection-conference/
Facebook https://www.facebook.com/HIPConf/

About Semperis

For security teams charged with defending hybrid and multi-cloud environments, Semperis ensures integrity and availability of critical enterprise directory services at every step in the cyber kill chain and cuts recovery time by 90%. Purpose-built for securing Active Directory, Semperis’ patented technology protects over 40 million identities from cyberattacks, data breaches, and operational errors. The world’s leading organisations trust Semperis to spot directory vulnerabilities, intercept cyberattacks in progress, and quickly recover from ransomware and other data integrity emergencies. Semperis is headquartered in New Jersey and operates internationally, with its research and development team distributed between San Francisco and Tel Aviv.

Semperis hosts the award-winning Hybrid Identity Protection conference (www.hipconf.com ). The company has received the highest level of industry accolades and was recently ranked the fourth fastest-growing company in the tri-state area and 35th overall in Deloitte’s 2020 Technology Fast 500™ . Semperis is accredited by Microsoft and recognised by Gartner.

Twitter https://twitter.com/SemperisTech
LinkedIn https://www.linkedin.com/company/semperis
Facebook https://www.facebook.com/SemperisTech
YouTube https://www.youtube.com/channel/UCycrWXhxOTaUQ0sidlyN9SA

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release

- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye